Hiddo Lambers Heerspink

Papers authored by Hiddo Lambers Heerspink

This paper was not found in any repository, but could be made available legally by the author.

2020 Skander Mulder

, Ann Hammarstedt, Sunil B. Nagaraj

, Viji Nair, Wenjun Ju

, Jonatan Hedberg, Peter J. Greasley, Jan W. Eriksson

, Jan Oscarsson, Hiddo J. L. Heerspink

A metabolomics‐based molecular pathway analysis of how the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes

Upload

This paper is made freely available by the publisher.

Sara Sokooti

, Tamas Szili-Torok, Jose L. Flores-Guerrero

, Maryse C. J. Osté

, António W. Gomes-Neto

, Jenny E. Kootstra-Ros, Hiddo J. L. Heerspink

, Margery A. Connelly

, Stephan J. L. Bakker

, Robin P. F. Dullaart

High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients

Download from doi.org

Stefanie A. Boer, Stefanie A. de Boer

, Melanie Reijrink

, Wayel H. Abdulahad, Elisa S. Hoekstra, Riemer H. J. A. Slart, Hiddo J. L. Heerspink

, Johanna Westra

, Douwe J. Mulder

Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin. A subanalysis from a randomized, placebo controlled trial (RELEASE study)

Download from api.wiley.com

Clare Arnott

, Jing-Wei Li, Dick Zeeuw, Dick de Zeeuw, Hiddo L. Heerspink, Christopher P. Cannon, Brendon L. Neuen

, Hiddo J. L. Heerspink

, Tom Greene, Adeera Levin, Mark D. Huffman, David M. Charytan

, Anubha Agarwal, Gemma A. Figtree, Carol Pollock and 11 other authors

The Effects of Canagliflozin on Heart Failure and Cardiovascular Death by Baseline Participant Characteristics: Analysis of the Credence Trial

Upload

2019 Rosalie A. Scholtes

, Daniël H. van Raalte

, Daniël H. Raalte, Ricardo Correa‐Rotter, Robert D. Toto, Hiddo J. L. Heerspink

, Valerie Cain, C. David Sjöström, Peter Sartipy, Bergur V. Stefánsson

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis

Download from onlinelibrary.wiley.com

Melanie Reijrink

, Stefanie A. de Boer, Daan S. Spoor, Joop D. Lefrandt, Hiddo J. Lambers Heerspink

, Ronald Boellaard, Marcel J.-W. Greuter, Ronald J. H. Borra, Jan-Luuk Hillebrands, Riemer H. J. A. Slart, Douwe J. Mulder

Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors

Upload

Mie K. Eickhoff, Claire C. J. Dekkers

, Bart J. Kramers, Gozewijn Dirk Laverman, Marie Frimodt-Møller

, Niklas Rye Jørgensen, Jens Faber

, A. H. Jan Danser, Ron T. Gansevoort, Peter Rossing, Frederik Persson, Hiddo J. L. Heerspink

Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors

Download from doi.org

2018 Lindsay E. Clegg

, Hiddo J. L. Heerspink

, Robert C. Penland

, Weifeng Tang, David W. Boulton, Srinivas Bachina, Robert D. Fox, Peter Fenici, Marcus Thuresson, Robert J. Mentz, Adrian F. Hernandez, Rury R. Holman

Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL

Upload

Andreas Heinzel

, Michael Kammer, Gert Mayer

, Roman Reindl-Schwaighofer, Karin Hu, Paul Perco

, Susanne Eder, Laszlo Rosivall, Patrick B. Mark, Wenjun Ju

, Matthias Kretzler, Peter Gilmour, Jonathan M. Wilson, Kevin L. Duffin, Moustafa Abdalla and 6 other authors

Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Hiddo Lambers Heerspink